Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Lilly presents another series of indole sPLA2 inhibitors

March 22, 2000

Spanish lab describes early research results in the area of COX-2 inhibitors

March 22, 2000

AstraZeneca synthesizes amide derivatives as cytokine production inhibitors

March 22, 2000

Lilly discloses new indole sPLA2 inhibitors

March 21, 2000

More good news about Enbrel: NEJM article describes efficacy in juvenile RA

March 20, 2000

Amides synthesized at AstraZeneca useful for cytokine-mediated diseases

March 17, 2000

Collgard receives orphan drug status for scleroderma therapy

March 15, 2000

New inhibitors of NOS, particularly iNOS, in early development at AstraZeneca

March 14, 2000

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

Suntory's new antiinflammatory agents act as inhibitors of NF-kB

March 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...